Context Therapeutics CNTX
NASDAQ CNTX
$0.23 -0.02 (-6.28%)
As of: Oct 21, 2026 · 3:04 PM EDT

Context Therapeutics (CNTX) Notes Payables (2020)

Updated

Context Therapeutics (CNTX) posted Notes Payables of $55,014 for Q4 2020.

Analysis

Context Therapeutics (CNTX) Notes Payables (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.82 Bn 1,105.41 Bn 19.71 Bn
2 Johnson & Johnson 617.41 Bn 535.94 Bn 17.26 Bn
3 AbbVie 501.29 Bn 474.40 Bn 12.70 Bn
4 Merck 368.15 Bn 322.53 Bn 12.21 Bn
5 Novartis Ag 297.07 Bn 261.06 Bn 11.24 Bn
6 Astrazeneca 260.90 Bn 234.58 Bn 12.86 Bn
7 Amgen 236.34 Bn 191.74 Bn 7.24 Bn
8 Gilead Sciences 191.00 Bn 165.20 Bn 6.22 Bn
9 Pfizer 169.72 Bn 116.36 Bn 10.94 Bn
10 Context Therapeutics 21.80 Mn -218.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 55,014.00
API Access

Context Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=CNTX&period=max&api_key=YOUR_API_KEY